Skip to main content
OpenTrials

Clinical trial condition

Lung Diseases, Interstitial

Explore clinical trials studying Lung Diseases, Interstitial. Study availability and eligibility vary by location and protocol.

737 public trials 132 recruiting studies
Refine in advanced search Browse all conditions

Lung Diseases, Interstitial trial results

Recruiting

DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers.

NCT07440290

Conditions
Adenocarcinoma, Adenocarcinoma, Papillary, Adnexal Diseases, +78 more
Locations
  • Belfast City Hospital Belfast, United Kingdom
  • University Hospital Birmingham Birmingham, United Kingdom
  • Birmingham Children's Hospital Birmingham, United Kingdom
  • Bristol Royal Hospital for Children Bristol, United Kingdom
View all 27 locations
View Trial Details
Recruiting

AURA-IPF: A Randomized Phase 2 Study to Evaluate the Safety and Efficacy of AP02 (Nintedanib Solution) in IPF

NCT07194382

Conditions
Idiopathic Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis (IPF), Lung Diseases, +3 more
Locations
  • Nepean Lung and Sleep Kingswood, New South Wales, Australia
  • Dynamic Drug Advancement Ajax, Ontario, Canada
  • CIC Mauricie Trois-Rivières, Quebec, Canada
  • Royal Prince Alfred Hospital Camperdown, New South Wales, Australia
View all 24 locations
View Trial Details
Recruiting

WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

NCT06967805

Conditions
Fibrosis, Idiopathic Pulmonary Fibrosis, Lung Diseases, +5 more
Locations
  • WISPer Site in Birmingham, AL Birmingham, Alabama, United States
  • WISPer site in Phoenix, AZ Phoenix, Arizona, United States
  • WISPer Site in Los Angeles, CA Los Angeles, California, United States
  • WISPer site in Newport Beach, CA Newport Beach, California, United States
View all 71 locations
View Trial Details
Recruiting

Efficacy and Safety Study of OATD-01 in Patients With Active Pulmonary Sarcoidosis

NCT06205121

Conditions
Hemic and Lymphatic Diseases, Hypersensitivity, Hypersensitivity, Delayed, +9 more
Locations
  • Molecure Investigative Site Birmingham, Alabama, United States
  • Molecure Investigative Site Kansas City, Kansas, United States
  • Molecure Investigative Site Baltimore, Maryland, United States
  • Molecure Investigative Site Rochester, Minnesota, United States
View all 28 locations
View Trial Details

Related conditions